---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-064485"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2023-03-08T23:59:59+00:00"
generated_at: "2026-06-18T08:36:47.469862+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology amends bylaws with enhanced stockholder nomination requirements and procedural updates

## Summary
- Eliminated requirement to make stockholder list available at meeting; added adjournment for technical failure.
- Enhanced disclosure requirements for stockholder nominations and proposals, including Rule 14a-19 compliance.
- Non-compliance with Rule 14a-19 may result in disregarding nominees and votes.
- Added emergency bylaw provision for director and officer authority during crises.
- Other technical, conforming, and clarifying changes made to reflect Delaware law.

## SEC filing metadata
- accession: 0001193125-23-064485
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2023-03-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000119312523064485/0001193125-23-064485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000119312523064485/d478454d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-064485
- JSON: https://secwatch.observer/filing/0001193125-23-064485.json
- Plain text: https://secwatch.observer/filing/0001193125-23-064485.txt

## Key facts
- Governance Changes
  Vir Biotechnology, Inc.: Amended and restated bylaws to reflect recent legal changes, procedural updates, and enhance stockholder proposal and director nomination requirements (effective 2023-03-02).
  - Change: bylaw amendment
  - Effective: 2023-03-02
  source text: On March 2, 2023, the Board of Directors of Vir Biotechnology, Inc. (the “Company”) unanimously adopted amended and restated bylaws of the Company (as so amended and restated, the “Bylaws”). The Bylaws, which became effective upon adoption, make modifications to reflect recent changes to applicable laws as well as certain procedural and other updates.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000119312523064485/0001193125-23-064485-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.